Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

European Commission supports new developments in biotechnology

22.12.2005


The European Commission today presents “100 Technology offers stemming from EU Biotechnology RTD results”, a catalogue of biotechnology developments arising from EU-funded research projects over the last 10 years. This guide will help to put researchers and companies in contact, hopefully leading to new and innovative products and processes based on this research. Examples featured in the catalogue include applications for food and plant biotechnology, biopharmaceuticals and biomedical technologies to support diagnostics and therapy. Each technology offer is described, including its potential for future commercial exploitation, and contact details are given for the researchers and the owners. “100 Technology Offers” is an example of how the European Commission is supporting the transformation of research into innovation.

Brussels, 20 December 2005

“Growth and jobs are fuelled by innovation and innovation is fed by research,” said Janez Potocnik, European Commissioner for Science and Research. “With this publication, the Commission is helping researchers to make their results known and put new technologies at the disposal of industry that can make the most of them.”



“100 biotechnology offers” includes results from the 4th, 5th and 6th Framework Programmes. Examples include:

- A small Slovenian company, BIA separations, which recently defended its intellectual property at the European Patent Office against big industry. The issue is one of monolithic chromatographic supports, which are used for the purification of pharmaceuticals and biologicals;

- Belgian start-up Cilbiotech, which improves the scale-up of cell cultivation for the production of human and veterinary vaccines. This new technology can for example increase the coverage of vaccines that may not currently be available to some sections of the population due to allergies.

All examples show that technologies developed by small biotech companies are ripe for future exploitation, and that issues relating to intellectual property need to be resolved if this is to take place in the best way.

Over the last 5-10 years, the Commission has required projects to develop a technological implementation plan, as part of making scientists aware of issues relating to intellectual property and entrepreneurship.

An online version of the booklet can be downloaded from: http://www.cordis.europa.eu.int/lifescihealth/src/leaflet.htm

Michael H. Wappelhorst | alfa
Further information:
http://www.cordis.europa.eu.int/lifescihealth/src/leaflet.htm

More articles from Life Sciences:

nachricht Immune Defense Without Collateral Damage
23.01.2017 | Universität Basel

nachricht The interactome of infected neural cells reveals new therapeutic targets for Zika
23.01.2017 | D'Or Institute for Research and Education

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Tracking movement of immune cells identifies key first steps in inflammatory arthritis

23.01.2017 | Health and Medicine

Electrocatalysis can advance green transition

23.01.2017 | Physics and Astronomy

New technology for mass-production of complex molded composite components

23.01.2017 | Process Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>